nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—NAT2—urinary bladder cancer	0.683	1	CbGaD
Clonazepam—ALB—Fluorouracil—urinary bladder cancer	0.0178	0.262	CbGbCtD
Clonazepam—CYP3A4—Thiotepa—urinary bladder cancer	0.0172	0.253	CbGbCtD
Clonazepam—NAT2—urine—urinary bladder cancer	0.0161	0.427	CbGeAlD
Clonazepam—CYP2E1—Etoposide—urinary bladder cancer	0.0154	0.226	CbGbCtD
Clonazepam—ALB—Methotrexate—urinary bladder cancer	0.00983	0.144	CbGbCtD
Clonazepam—CYP3A4—Etoposide—urinary bladder cancer	0.00466	0.0685	CbGbCtD
Clonazepam—NAT2—renal system—urinary bladder cancer	0.00393	0.105	CbGeAlD
Clonazepam—CYP3A4—Doxorubicin—urinary bladder cancer	0.00318	0.0467	CbGbCtD
Clonazepam—CYP2E1—urine—urinary bladder cancer	0.00237	0.063	CbGeAlD
Clonazepam—CYP3A4—urine—urinary bladder cancer	0.00191	0.0507	CbGeAlD
Clonazepam—TSPO—prostate gland—urinary bladder cancer	0.00147	0.0392	CbGeAlD
Clonazepam—Midazolam—CYP4B1—urinary bladder cancer	0.00138	0.513	CrCbGaD
Clonazepam—TSPO—seminal vesicle—urinary bladder cancer	0.00125	0.0331	CbGeAlD
Clonazepam—TSPO—epithelium—urinary bladder cancer	0.00108	0.0288	CbGeAlD
Clonazepam—TSPO—smooth muscle tissue—urinary bladder cancer	0.00104	0.0277	CbGeAlD
Clonazepam—TSPO—renal system—urinary bladder cancer	0.001	0.0267	CbGeAlD
Clonazepam—TSPO—urethra—urinary bladder cancer	0.000986	0.0262	CbGeAlD
Clonazepam—CYP2E1—prostate gland—urinary bladder cancer	0.000851	0.0226	CbGeAlD
Clonazepam—TSPO—female reproductive system—urinary bladder cancer	0.000804	0.0214	CbGeAlD
Clonazepam—Flunitrazepam—UGT2B7—urinary bladder cancer	0.00074	0.274	CrCbGaD
Clonazepam—TSPO—vagina—urinary bladder cancer	0.000727	0.0193	CbGeAlD
Clonazepam—CYP2E1—seminal vesicle—urinary bladder cancer	0.00072	0.0191	CbGeAlD
Clonazepam—CYP2E1—renal system—urinary bladder cancer	0.00058	0.0154	CbGeAlD
Clonazepam—Oxazepam—UGT2B7—urinary bladder cancer	0.000575	0.213	CrCbGaD
Clonazepam—CYP2E1—urethra—urinary bladder cancer	0.00057	0.0151	CbGeAlD
Clonazepam—TSPO—lymph node—urinary bladder cancer	0.00047	0.0125	CbGeAlD
Clonazepam—CYP3A4—renal system—urinary bladder cancer	0.000467	0.0124	CbGeAlD
Clonazepam—CYP2E1—female reproductive system—urinary bladder cancer	0.000464	0.0123	CbGeAlD
Clonazepam—ALB—lymph node—urinary bladder cancer	0.000459	0.0122	CbGeAlD
Clonazepam—CYP2E1—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000401	0.00522	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000393	0.00512	CbGpPWpGaD
Clonazepam—CYP3A4—female reproductive system—urinary bladder cancer	0.000374	0.00994	CbGeAlD
Clonazepam—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000346	0.00449	CbGpPWpGaD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00033	0.00428	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—SLC19A1—urinary bladder cancer	0.000306	0.00397	CbGpPWpGaD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000297	0.00386	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—GSTP1—urinary bladder cancer	0.000295	0.00384	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000291	0.00379	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—GSTM1—urinary bladder cancer	0.000271	0.00353	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000268	0.00348	CbGpPWpGaD
Clonazepam—GABRB2—Ion channel transport—TRPV1—urinary bladder cancer	0.000247	0.00321	CbGpPWpGaD
Clonazepam—GABRA3—Ion channel transport—TRPV1—urinary bladder cancer	0.000235	0.00306	CbGpPWpGaD
Clonazepam—GABRG2—Ion channel transport—TRPV1—urinary bladder cancer	0.000226	0.00294	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTZ1—urinary bladder cancer	0.000224	0.00292	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000221	0.00288	CbGpPWpGaD
Clonazepam—ALB—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.000216	0.00281	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTO2—urinary bladder cancer	0.000213	0.00276	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—NAT1—urinary bladder cancer	0.000213	0.00276	CbGpPWpGaD
Clonazepam—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000212	0.00275	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00021	0.00273	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.000209	0.00272	CbGpPWpGaD
Clonazepam—GABRA1—Ion channel transport—TRPV1—urinary bladder cancer	0.000197	0.00257	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000194	0.00253	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000192	0.00249	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000189	0.00245	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000186	0.00242	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTZ1—urinary bladder cancer	0.000181	0.00235	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000175	0.00228	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000173	0.00224	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTO2—urinary bladder cancer	0.000171	0.00223	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NAT1—urinary bladder cancer	0.000171	0.00223	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—MPO—urinary bladder cancer	0.00017	0.00221	CbGpPWpGaD
Clonazepam—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000162	0.00211	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—UGT2B7—urinary bladder cancer	0.000157	0.00204	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000153	0.00199	CbGpPWpGaD
Clonazepam—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000152	0.00198	CbGpPWpGaD
Clonazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000151	0.00196	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000146	0.0019	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP4B1—urinary bladder cancer	0.000141	0.00184	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000139	0.00181	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000135	0.00176	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—SLC19A1—urinary bladder cancer	0.000133	0.00173	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000133	0.00173	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000131	0.00171	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.000131	0.00171	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PRSS3—urinary bladder cancer	0.00013	0.00169	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000121	0.00157	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000117	0.00152	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—NAT2—urinary bladder cancer	0.000116	0.00151	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.000116	0.0015	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000115	0.00149	CbGpPWpGaD
Clonazepam—GABRB2—Orphan transporters—CREBBP—urinary bladder cancer	0.000111	0.00145	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—SOD2—urinary bladder cancer	0.000107	0.00139	CbGpPWpGaD
Clonazepam—GABRA3—Orphan transporters—CREBBP—urinary bladder cancer	0.000106	0.00138	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000105	0.00137	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000104	0.00135	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—TYMP—urinary bladder cancer	0.000104	0.00135	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000103	0.00133	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—GPX1—urinary bladder cancer	0.000102	0.00132	CbGpPWpGaD
Clonazepam—GABRG2—Orphan transporters—CREBBP—urinary bladder cancer	0.000102	0.00132	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000101	0.00131	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	9.86e-05	0.00128	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	9.86e-05	0.00128	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	9.73e-05	0.00126	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	9.64e-05	0.00125	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—MTHFR—urinary bladder cancer	9.4e-05	0.00122	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	9.31e-05	0.00121	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	9.03e-05	0.00117	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	9.02e-05	0.00117	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	8.9e-05	0.00116	CbGpPWpGaD
Clonazepam—GABRA1—Orphan transporters—CREBBP—urinary bladder cancer	8.89e-05	0.00116	CbGpPWpGaD
Clonazepam—Weight increased—Doxorubicin—urinary bladder cancer	8.85e-05	0.000672	CcSEcCtD
Clonazepam—Epistaxis—Epirubicin—urinary bladder cancer	8.84e-05	0.000672	CcSEcCtD
Clonazepam—Pruritus—Gemcitabine—urinary bladder cancer	8.83e-05	0.000671	CcSEcCtD
Clonazepam—Nausea—Thiotepa—urinary bladder cancer	8.81e-05	0.00067	CcSEcCtD
Clonazepam—Urethral disorder—Methotrexate—urinary bladder cancer	8.81e-05	0.00067	CcSEcCtD
Clonazepam—Weight decreased—Doxorubicin—urinary bladder cancer	8.8e-05	0.000668	CcSEcCtD
Clonazepam—Sinusitis—Epirubicin—urinary bladder cancer	8.79e-05	0.000668	CcSEcCtD
Clonazepam—Feeling abnormal—Etoposide—urinary bladder cancer	8.78e-05	0.000668	CcSEcCtD
Clonazepam—Pneumonia—Doxorubicin—urinary bladder cancer	8.72e-05	0.000663	CcSEcCtD
Clonazepam—Gastrointestinal pain—Etoposide—urinary bladder cancer	8.72e-05	0.000662	CcSEcCtD
Clonazepam—Pruritus—Fluorouracil—urinary bladder cancer	8.68e-05	0.00066	CcSEcCtD
Clonazepam—Drowsiness—Doxorubicin—urinary bladder cancer	8.67e-05	0.000659	CcSEcCtD
Clonazepam—Visual impairment—Methotrexate—urinary bladder cancer	8.66e-05	0.000658	CcSEcCtD
Clonazepam—GABRB2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.59e-05	0.00112	CbGpPWpGaD
Clonazepam—Hypersensitivity—Cisplatin—urinary bladder cancer	8.57e-05	0.000651	CcSEcCtD
Clonazepam—Diarrhoea—Gemcitabine—urinary bladder cancer	8.54e-05	0.000649	CcSEcCtD
Clonazepam—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	8.5e-05	0.000646	CcSEcCtD
Clonazepam—ALB—Selenium Micronutrient Network—SOD2—urinary bladder cancer	8.48e-05	0.0011	CbGpPWpGaD
Clonazepam—Urticaria—Etoposide—urinary bladder cancer	8.47e-05	0.000644	CcSEcCtD
Clonazepam—Haemoglobin—Epirubicin—urinary bladder cancer	8.45e-05	0.000642	CcSEcCtD
Clonazepam—Rhinitis—Epirubicin—urinary bladder cancer	8.43e-05	0.000641	CcSEcCtD
Clonazepam—Body temperature increased—Etoposide—urinary bladder cancer	8.43e-05	0.00064	CcSEcCtD
Clonazepam—Abdominal pain—Etoposide—urinary bladder cancer	8.43e-05	0.00064	CcSEcCtD
Clonazepam—Urinary tract infection—Doxorubicin—urinary bladder cancer	8.43e-05	0.00064	CcSEcCtD
Clonazepam—GABRA1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8.42e-05	0.0011	CbGpPWpGaD
Clonazepam—Haemorrhage—Epirubicin—urinary bladder cancer	8.41e-05	0.000639	CcSEcCtD
Clonazepam—Eye disorder—Methotrexate—urinary bladder cancer	8.4e-05	0.000638	CcSEcCtD
Clonazepam—Diarrhoea—Fluorouracil—urinary bladder cancer	8.4e-05	0.000638	CcSEcCtD
Clonazepam—Hypoaesthesia—Epirubicin—urinary bladder cancer	8.37e-05	0.000636	CcSEcCtD
Clonazepam—Asthenia—Cisplatin—urinary bladder cancer	8.35e-05	0.000634	CcSEcCtD
Clonazepam—Pharyngitis—Epirubicin—urinary bladder cancer	8.35e-05	0.000634	CcSEcCtD
Clonazepam—Cardiac disorder—Methotrexate—urinary bladder cancer	8.34e-05	0.000634	CcSEcCtD
Clonazepam—Urinary tract disorder—Epirubicin—urinary bladder cancer	8.31e-05	0.000631	CcSEcCtD
Clonazepam—Oedema peripheral—Epirubicin—urinary bladder cancer	8.29e-05	0.00063	CcSEcCtD
Clonazepam—Connective tissue disorder—Epirubicin—urinary bladder cancer	8.27e-05	0.000628	CcSEcCtD
Clonazepam—Urethral disorder—Epirubicin—urinary bladder cancer	8.24e-05	0.000627	CcSEcCtD
Clonazepam—GABRA3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.2e-05	0.00107	CbGpPWpGaD
Clonazepam—Epistaxis—Doxorubicin—urinary bladder cancer	8.18e-05	0.000621	CcSEcCtD
Clonazepam—Sinusitis—Doxorubicin—urinary bladder cancer	8.13e-05	0.000618	CcSEcCtD
Clonazepam—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	8.12e-05	0.00106	CbGpPWpGaD
Clonazepam—Immune system disorder—Methotrexate—urinary bladder cancer	8.12e-05	0.000617	CcSEcCtD
Clonazepam—Dizziness—Fluorouracil—urinary bladder cancer	8.12e-05	0.000617	CcSEcCtD
Clonazepam—NAT2—Metabolism—RRM2—urinary bladder cancer	8.11e-05	0.00105	CbGpPWpGaD
Clonazepam—Visual impairment—Epirubicin—urinary bladder cancer	8.11e-05	0.000616	CcSEcCtD
Clonazepam—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	8.09e-05	0.00105	CbGpPWpGaD
Clonazepam—Chills—Methotrexate—urinary bladder cancer	8.06e-05	0.000613	CcSEcCtD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	8.01e-05	0.00104	CbGpPWpGaD
Clonazepam—Diarrhoea—Cisplatin—urinary bladder cancer	7.96e-05	0.000605	CcSEcCtD
Clonazepam—Alopecia—Methotrexate—urinary bladder cancer	7.94e-05	0.000604	CcSEcCtD
Clonazepam—Vomiting—Gemcitabine—urinary bladder cancer	7.94e-05	0.000603	CcSEcCtD
Clonazepam—Mental disorder—Methotrexate—urinary bladder cancer	7.87e-05	0.000598	CcSEcCtD
Clonazepam—Rash—Gemcitabine—urinary bladder cancer	7.87e-05	0.000598	CcSEcCtD
Clonazepam—Dermatitis—Gemcitabine—urinary bladder cancer	7.86e-05	0.000598	CcSEcCtD
Clonazepam—Eye disorder—Epirubicin—urinary bladder cancer	7.86e-05	0.000597	CcSEcCtD
Clonazepam—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.86e-05	0.00102	CbGpPWpGaD
Clonazepam—Hypersensitivity—Etoposide—urinary bladder cancer	7.85e-05	0.000597	CcSEcCtD
Clonazepam—Malnutrition—Methotrexate—urinary bladder cancer	7.82e-05	0.000595	CcSEcCtD
Clonazepam—Haemoglobin—Doxorubicin—urinary bladder cancer	7.82e-05	0.000594	CcSEcCtD
Clonazepam—Headache—Gemcitabine—urinary bladder cancer	7.82e-05	0.000594	CcSEcCtD
Clonazepam—Flushing—Epirubicin—urinary bladder cancer	7.81e-05	0.000593	CcSEcCtD
Clonazepam—Cardiac disorder—Epirubicin—urinary bladder cancer	7.81e-05	0.000593	CcSEcCtD
Clonazepam—Vomiting—Fluorouracil—urinary bladder cancer	7.8e-05	0.000593	CcSEcCtD
Clonazepam—Rhinitis—Doxorubicin—urinary bladder cancer	7.8e-05	0.000593	CcSEcCtD
Clonazepam—Haemorrhage—Doxorubicin—urinary bladder cancer	7.78e-05	0.000591	CcSEcCtD
Clonazepam—Hypoaesthesia—Doxorubicin—urinary bladder cancer	7.74e-05	0.000588	CcSEcCtD
Clonazepam—Rash—Fluorouracil—urinary bladder cancer	7.74e-05	0.000588	CcSEcCtD
Clonazepam—Dermatitis—Fluorouracil—urinary bladder cancer	7.73e-05	0.000588	CcSEcCtD
Clonazepam—Pharyngitis—Doxorubicin—urinary bladder cancer	7.72e-05	0.000587	CcSEcCtD
Clonazepam—Headache—Fluorouracil—urinary bladder cancer	7.69e-05	0.000584	CcSEcCtD
Clonazepam—Urinary tract disorder—Doxorubicin—urinary bladder cancer	7.69e-05	0.000584	CcSEcCtD
Clonazepam—Oedema peripheral—Doxorubicin—urinary bladder cancer	7.67e-05	0.000583	CcSEcCtD
Clonazepam—Asthenia—Etoposide—urinary bladder cancer	7.65e-05	0.000581	CcSEcCtD
Clonazepam—Connective tissue disorder—Doxorubicin—urinary bladder cancer	7.65e-05	0.000581	CcSEcCtD
Clonazepam—Urethral disorder—Doxorubicin—urinary bladder cancer	7.63e-05	0.00058	CcSEcCtD
Clonazepam—Immune system disorder—Epirubicin—urinary bladder cancer	7.6e-05	0.000577	CcSEcCtD
Clonazepam—Back pain—Methotrexate—urinary bladder cancer	7.57e-05	0.000575	CcSEcCtD
Clonazepam—Chills—Epirubicin—urinary bladder cancer	7.55e-05	0.000573	CcSEcCtD
Clonazepam—Pruritus—Etoposide—urinary bladder cancer	7.54e-05	0.000573	CcSEcCtD
Clonazepam—NAT2—Metabolism—ENO2—urinary bladder cancer	7.51e-05	0.000977	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—HPGDS—urinary bladder cancer	7.51e-05	0.000977	CbGpPWpGaD
Clonazepam—Visual impairment—Doxorubicin—urinary bladder cancer	7.5e-05	0.00057	CcSEcCtD
Clonazepam—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	7.47e-05	0.000971	CbGpPWpGaD
Clonazepam—Alopecia—Epirubicin—urinary bladder cancer	7.43e-05	0.000565	CcSEcCtD
Clonazepam—Nausea—Gemcitabine—urinary bladder cancer	7.42e-05	0.000564	CcSEcCtD
Clonazepam—Vomiting—Cisplatin—urinary bladder cancer	7.4e-05	0.000562	CcSEcCtD
Clonazepam—Vision blurred—Methotrexate—urinary bladder cancer	7.37e-05	0.00056	CcSEcCtD
Clonazepam—Mental disorder—Epirubicin—urinary bladder cancer	7.37e-05	0.00056	CcSEcCtD
Clonazepam—Rash—Cisplatin—urinary bladder cancer	7.34e-05	0.000558	CcSEcCtD
Clonazepam—Dermatitis—Cisplatin—urinary bladder cancer	7.33e-05	0.000557	CcSEcCtD
Clonazepam—Malnutrition—Epirubicin—urinary bladder cancer	7.32e-05	0.000556	CcSEcCtD
Clonazepam—Diarrhoea—Etoposide—urinary bladder cancer	7.29e-05	0.000554	CcSEcCtD
Clonazepam—Nausea—Fluorouracil—urinary bladder cancer	7.29e-05	0.000554	CcSEcCtD
Clonazepam—NAT2—Metabolism—GSTT1—urinary bladder cancer	7.29e-05	0.000947	CbGpPWpGaD
Clonazepam—Eye disorder—Doxorubicin—urinary bladder cancer	7.27e-05	0.000553	CcSEcCtD
Clonazepam—Ill-defined disorder—Methotrexate—urinary bladder cancer	7.26e-05	0.000552	CcSEcCtD
Clonazepam—Anaemia—Methotrexate—urinary bladder cancer	7.23e-05	0.00055	CcSEcCtD
Clonazepam—Flushing—Doxorubicin—urinary bladder cancer	7.22e-05	0.000549	CcSEcCtD
Clonazepam—Cardiac disorder—Doxorubicin—urinary bladder cancer	7.22e-05	0.000549	CcSEcCtD
Clonazepam—Flatulence—Epirubicin—urinary bladder cancer	7.21e-05	0.000548	CcSEcCtD
Clonazepam—Tension—Epirubicin—urinary bladder cancer	7.18e-05	0.000546	CcSEcCtD
Clonazepam—Nervousness—Epirubicin—urinary bladder cancer	7.11e-05	0.00054	CcSEcCtD
Clonazepam—Back pain—Epirubicin—urinary bladder cancer	7.08e-05	0.000538	CcSEcCtD
Clonazepam—Malaise—Methotrexate—urinary bladder cancer	7.06e-05	0.000536	CcSEcCtD
Clonazepam—Dizziness—Etoposide—urinary bladder cancer	7.05e-05	0.000536	CcSEcCtD
Clonazepam—Muscle spasms—Epirubicin—urinary bladder cancer	7.04e-05	0.000535	CcSEcCtD
Clonazepam—Immune system disorder—Doxorubicin—urinary bladder cancer	7.03e-05	0.000534	CcSEcCtD
Clonazepam—Vertigo—Methotrexate—urinary bladder cancer	7.03e-05	0.000534	CcSEcCtD
Clonazepam—Leukopenia—Methotrexate—urinary bladder cancer	7e-05	0.000532	CcSEcCtD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	7e-05	0.00091	CbGpPWpGaD
Clonazepam—Chills—Doxorubicin—urinary bladder cancer	6.98e-05	0.000531	CcSEcCtD
Clonazepam—Nausea—Cisplatin—urinary bladder cancer	6.91e-05	0.000525	CcSEcCtD
Clonazepam—Vision blurred—Epirubicin—urinary bladder cancer	6.9e-05	0.000524	CcSEcCtD
Clonazepam—Alopecia—Doxorubicin—urinary bladder cancer	6.88e-05	0.000523	CcSEcCtD
Clonazepam—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.87e-05	0.000893	CbGpPWpGaD
Clonazepam—Cough—Methotrexate—urinary bladder cancer	6.83e-05	0.000519	CcSEcCtD
Clonazepam—Mental disorder—Doxorubicin—urinary bladder cancer	6.82e-05	0.000518	CcSEcCtD
Clonazepam—Ill-defined disorder—Epirubicin—urinary bladder cancer	6.79e-05	0.000516	CcSEcCtD
Clonazepam—Vomiting—Etoposide—urinary bladder cancer	6.78e-05	0.000515	CcSEcCtD
Clonazepam—Malnutrition—Doxorubicin—urinary bladder cancer	6.77e-05	0.000515	CcSEcCtD
Clonazepam—Anaemia—Epirubicin—urinary bladder cancer	6.77e-05	0.000514	CcSEcCtD
Clonazepam—Agitation—Epirubicin—urinary bladder cancer	6.73e-05	0.000511	CcSEcCtD
Clonazepam—Rash—Etoposide—urinary bladder cancer	6.72e-05	0.000511	CcSEcCtD
Clonazepam—Dermatitis—Etoposide—urinary bladder cancer	6.72e-05	0.00051	CcSEcCtD
Clonazepam—Headache—Etoposide—urinary bladder cancer	6.68e-05	0.000507	CcSEcCtD
Clonazepam—Flatulence—Doxorubicin—urinary bladder cancer	6.68e-05	0.000507	CcSEcCtD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	6.67e-05	0.000867	CbGpPWpGaD
Clonazepam—Chest pain—Methotrexate—urinary bladder cancer	6.66e-05	0.000506	CcSEcCtD
Clonazepam—Arthralgia—Methotrexate—urinary bladder cancer	6.66e-05	0.000506	CcSEcCtD
Clonazepam—Myalgia—Methotrexate—urinary bladder cancer	6.66e-05	0.000506	CcSEcCtD
Clonazepam—Tension—Doxorubicin—urinary bladder cancer	6.65e-05	0.000505	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	6.61e-05	0.000503	CcSEcCtD
Clonazepam—Malaise—Epirubicin—urinary bladder cancer	6.6e-05	0.000502	CcSEcCtD
Clonazepam—Discomfort—Methotrexate—urinary bladder cancer	6.58e-05	0.0005	CcSEcCtD
Clonazepam—Nervousness—Doxorubicin—urinary bladder cancer	6.58e-05	0.0005	CcSEcCtD
Clonazepam—Vertigo—Epirubicin—urinary bladder cancer	6.58e-05	0.0005	CcSEcCtD
Clonazepam—Leukopenia—Epirubicin—urinary bladder cancer	6.55e-05	0.000498	CcSEcCtD
Clonazepam—Back pain—Doxorubicin—urinary bladder cancer	6.55e-05	0.000498	CcSEcCtD
Clonazepam—Muscle spasms—Doxorubicin—urinary bladder cancer	6.51e-05	0.000495	CcSEcCtD
Clonazepam—Palpitations—Epirubicin—urinary bladder cancer	6.47e-05	0.000492	CcSEcCtD
Clonazepam—Confusional state—Methotrexate—urinary bladder cancer	6.44e-05	0.000489	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	6.43e-05	0.000836	CbGpPWpGaD
Clonazepam—Cough—Epirubicin—urinary bladder cancer	6.39e-05	0.000486	CcSEcCtD
Clonazepam—Anaphylactic shock—Methotrexate—urinary bladder cancer	6.39e-05	0.000485	CcSEcCtD
Clonazepam—Vision blurred—Doxorubicin—urinary bladder cancer	6.38e-05	0.000485	CcSEcCtD
Clonazepam—Infection—Methotrexate—urinary bladder cancer	6.34e-05	0.000482	CcSEcCtD
Clonazepam—Nausea—Etoposide—urinary bladder cancer	6.33e-05	0.000481	CcSEcCtD
Clonazepam—Ill-defined disorder—Doxorubicin—urinary bladder cancer	6.29e-05	0.000478	CcSEcCtD
Clonazepam—Nervous system disorder—Methotrexate—urinary bladder cancer	6.26e-05	0.000476	CcSEcCtD
Clonazepam—Anaemia—Doxorubicin—urinary bladder cancer	6.26e-05	0.000476	CcSEcCtD
Clonazepam—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	6.26e-05	0.000814	CbGpPWpGaD
Clonazepam—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.25e-05	0.000475	CcSEcCtD
Clonazepam—Arthralgia—Epirubicin—urinary bladder cancer	6.23e-05	0.000474	CcSEcCtD
Clonazepam—Chest pain—Epirubicin—urinary bladder cancer	6.23e-05	0.000474	CcSEcCtD
Clonazepam—Myalgia—Epirubicin—urinary bladder cancer	6.23e-05	0.000474	CcSEcCtD
Clonazepam—Agitation—Doxorubicin—urinary bladder cancer	6.23e-05	0.000473	CcSEcCtD
Clonazepam—Anxiety—Epirubicin—urinary bladder cancer	6.21e-05	0.000472	CcSEcCtD
Clonazepam—Skin disorder—Methotrexate—urinary bladder cancer	6.2e-05	0.000471	CcSEcCtD
Clonazepam—ALB—Platelet degranulation—IGF1—urinary bladder cancer	6.2e-05	0.000806	CbGpPWpGaD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	6.19e-05	0.00047	CcSEcCtD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.17e-05	0.000803	CbGpPWpGaD
Clonazepam—Discomfort—Epirubicin—urinary bladder cancer	6.16e-05	0.000468	CcSEcCtD
Clonazepam—Malaise—Doxorubicin—urinary bladder cancer	6.11e-05	0.000464	CcSEcCtD
Clonazepam—Dry mouth—Epirubicin—urinary bladder cancer	6.1e-05	0.000463	CcSEcCtD
Clonazepam—Vertigo—Doxorubicin—urinary bladder cancer	6.09e-05	0.000463	CcSEcCtD
Clonazepam—Anorexia—Methotrexate—urinary bladder cancer	6.09e-05	0.000463	CcSEcCtD
Clonazepam—Leukopenia—Doxorubicin—urinary bladder cancer	6.06e-05	0.000461	CcSEcCtD
Clonazepam—NAT2—Metabolism—NQO1—urinary bladder cancer	6.05e-05	0.000787	CbGpPWpGaD
Clonazepam—Confusional state—Epirubicin—urinary bladder cancer	6.03e-05	0.000458	CcSEcCtD
Clonazepam—Palpitations—Doxorubicin—urinary bladder cancer	5.99e-05	0.000455	CcSEcCtD
Clonazepam—Oedema—Epirubicin—urinary bladder cancer	5.98e-05	0.000454	CcSEcCtD
Clonazepam—Anaphylactic shock—Epirubicin—urinary bladder cancer	5.98e-05	0.000454	CcSEcCtD
Clonazepam—Hypotension—Methotrexate—urinary bladder cancer	5.97e-05	0.000453	CcSEcCtD
Clonazepam—Infection—Epirubicin—urinary bladder cancer	5.94e-05	0.000451	CcSEcCtD
Clonazepam—Cough—Doxorubicin—urinary bladder cancer	5.91e-05	0.000449	CcSEcCtD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	5.91e-05	0.000768	CbGpPWpGaD
Clonazepam—Nervous system disorder—Epirubicin—urinary bladder cancer	5.86e-05	0.000445	CcSEcCtD
Clonazepam—Thrombocytopenia—Epirubicin—urinary bladder cancer	5.85e-05	0.000445	CcSEcCtD
Clonazepam—Tachycardia—Epirubicin—urinary bladder cancer	5.83e-05	0.000443	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	5.82e-05	0.000442	CcSEcCtD
Clonazepam—Skin disorder—Epirubicin—urinary bladder cancer	5.8e-05	0.000441	CcSEcCtD
Clonazepam—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.8e-05	0.000755	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	5.78e-05	0.000751	CbGpPWpGaD
Clonazepam—Insomnia—Methotrexate—urinary bladder cancer	5.78e-05	0.000439	CcSEcCtD
Clonazepam—Myalgia—Doxorubicin—urinary bladder cancer	5.77e-05	0.000438	CcSEcCtD
Clonazepam—Chest pain—Doxorubicin—urinary bladder cancer	5.77e-05	0.000438	CcSEcCtD
Clonazepam—Arthralgia—Doxorubicin—urinary bladder cancer	5.77e-05	0.000438	CcSEcCtD
Clonazepam—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	5.75e-05	0.000748	CbGpPWpGaD
Clonazepam—Anxiety—Doxorubicin—urinary bladder cancer	5.75e-05	0.000437	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	5.73e-05	0.000435	CcSEcCtD
Clonazepam—Discomfort—Doxorubicin—urinary bladder cancer	5.7e-05	0.000433	CcSEcCtD
Clonazepam—Anorexia—Epirubicin—urinary bladder cancer	5.7e-05	0.000433	CcSEcCtD
Clonazepam—Dyspnoea—Methotrexate—urinary bladder cancer	5.69e-05	0.000433	CcSEcCtD
Clonazepam—Somnolence—Methotrexate—urinary bladder cancer	5.68e-05	0.000431	CcSEcCtD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.67e-05	0.000738	CbGpPWpGaD
Clonazepam—Dry mouth—Doxorubicin—urinary bladder cancer	5.64e-05	0.000429	CcSEcCtD
Clonazepam—Dyspepsia—Methotrexate—urinary bladder cancer	5.62e-05	0.000427	CcSEcCtD
Clonazepam—Hypotension—Epirubicin—urinary bladder cancer	5.58e-05	0.000424	CcSEcCtD
Clonazepam—Confusional state—Doxorubicin—urinary bladder cancer	5.57e-05	0.000424	CcSEcCtD
Clonazepam—ALB—Folate Metabolism—IL2—urinary bladder cancer	5.56e-05	0.000723	CbGpPWpGaD
Clonazepam—Decreased appetite—Methotrexate—urinary bladder cancer	5.55e-05	0.000422	CcSEcCtD
Clonazepam—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.54e-05	0.00072	CbGpPWpGaD
Clonazepam—Oedema—Doxorubicin—urinary bladder cancer	5.53e-05	0.00042	CcSEcCtD
Clonazepam—Anaphylactic shock—Doxorubicin—urinary bladder cancer	5.53e-05	0.00042	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	5.51e-05	0.000419	CcSEcCtD
Clonazepam—Fatigue—Methotrexate—urinary bladder cancer	5.5e-05	0.000418	CcSEcCtD
Clonazepam—Infection—Doxorubicin—urinary bladder cancer	5.49e-05	0.000417	CcSEcCtD
Clonazepam—Pain—Methotrexate—urinary bladder cancer	5.46e-05	0.000415	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.44e-05	0.000414	CcSEcCtD
Clonazepam—Nervous system disorder—Doxorubicin—urinary bladder cancer	5.42e-05	0.000412	CcSEcCtD
Clonazepam—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.41e-05	0.000411	CcSEcCtD
Clonazepam—Insomnia—Epirubicin—urinary bladder cancer	5.4e-05	0.000411	CcSEcCtD
Clonazepam—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	5.4e-05	0.000703	CbGpPWpGaD
Clonazepam—Tachycardia—Doxorubicin—urinary bladder cancer	5.4e-05	0.00041	CcSEcCtD
Clonazepam—Skin disorder—Doxorubicin—urinary bladder cancer	5.37e-05	0.000408	CcSEcCtD
Clonazepam—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	5.33e-05	0.000693	CbGpPWpGaD
Clonazepam—Dyspnoea—Epirubicin—urinary bladder cancer	5.33e-05	0.000405	CcSEcCtD
Clonazepam—Somnolence—Epirubicin—urinary bladder cancer	5.31e-05	0.000404	CcSEcCtD
Clonazepam—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.31e-05	0.00069	CbGpPWpGaD
Clonazepam—Anorexia—Doxorubicin—urinary bladder cancer	5.27e-05	0.000401	CcSEcCtD
Clonazepam—Feeling abnormal—Methotrexate—urinary bladder cancer	5.26e-05	0.0004	CcSEcCtD
Clonazepam—Dyspepsia—Epirubicin—urinary bladder cancer	5.26e-05	0.0004	CcSEcCtD
Clonazepam—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.22e-05	0.000397	CcSEcCtD
Clonazepam—Decreased appetite—Epirubicin—urinary bladder cancer	5.19e-05	0.000395	CcSEcCtD
Clonazepam—Hypotension—Doxorubicin—urinary bladder cancer	5.17e-05	0.000393	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	5.16e-05	0.000392	CcSEcCtD
Clonazepam—Fatigue—Epirubicin—urinary bladder cancer	5.15e-05	0.000392	CcSEcCtD
Clonazepam—Constipation—Epirubicin—urinary bladder cancer	5.11e-05	0.000388	CcSEcCtD
Clonazepam—Pain—Epirubicin—urinary bladder cancer	5.11e-05	0.000388	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	5.11e-05	0.000664	CbGpPWpGaD
Clonazepam—Urticaria—Methotrexate—urinary bladder cancer	5.07e-05	0.000385	CcSEcCtD
Clonazepam—NAT2—Metabolism—GSTP1—urinary bladder cancer	5.05e-05	0.000657	CbGpPWpGaD
Clonazepam—Abdominal pain—Methotrexate—urinary bladder cancer	5.05e-05	0.000384	CcSEcCtD
Clonazepam—Body temperature increased—Methotrexate—urinary bladder cancer	5.05e-05	0.000384	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.04e-05	0.000383	CcSEcCtD
Clonazepam—Insomnia—Doxorubicin—urinary bladder cancer	5e-05	0.00038	CcSEcCtD
Clonazepam—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	4.98e-05	0.000647	CbGpPWpGaD
Clonazepam—Dyspnoea—Doxorubicin—urinary bladder cancer	4.93e-05	0.000375	CcSEcCtD
Clonazepam—Feeling abnormal—Epirubicin—urinary bladder cancer	4.92e-05	0.000374	CcSEcCtD
Clonazepam—Somnolence—Doxorubicin—urinary bladder cancer	4.92e-05	0.000374	CcSEcCtD
Clonazepam—Gastrointestinal pain—Epirubicin—urinary bladder cancer	4.89e-05	0.000371	CcSEcCtD
Clonazepam—Dyspepsia—Doxorubicin—urinary bladder cancer	4.87e-05	0.00037	CcSEcCtD
Clonazepam—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.82e-05	0.000627	CbGpPWpGaD
Clonazepam—Decreased appetite—Doxorubicin—urinary bladder cancer	4.81e-05	0.000365	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	4.77e-05	0.000363	CcSEcCtD
Clonazepam—Fatigue—Doxorubicin—urinary bladder cancer	4.77e-05	0.000362	CcSEcCtD
Clonazepam—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	4.76e-05	0.000619	CbGpPWpGaD
Clonazepam—Urticaria—Epirubicin—urinary bladder cancer	4.75e-05	0.000361	CcSEcCtD
Clonazepam—Pain—Doxorubicin—urinary bladder cancer	4.73e-05	0.000359	CcSEcCtD
Clonazepam—Constipation—Doxorubicin—urinary bladder cancer	4.73e-05	0.000359	CcSEcCtD
Clonazepam—Body temperature increased—Epirubicin—urinary bladder cancer	4.72e-05	0.000359	CcSEcCtD
Clonazepam—Abdominal pain—Epirubicin—urinary bladder cancer	4.72e-05	0.000359	CcSEcCtD
Clonazepam—Hypersensitivity—Methotrexate—urinary bladder cancer	4.7e-05	0.000357	CcSEcCtD
Clonazepam—NAT2—Metabolism—TYMS—urinary bladder cancer	4.69e-05	0.00061	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTM1—urinary bladder cancer	4.64e-05	0.000603	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NCOR1—urinary bladder cancer	4.64e-05	0.000603	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.64e-05	0.000603	CbGpPWpGaD
Clonazepam—Asthenia—Methotrexate—urinary bladder cancer	4.58e-05	0.000348	CcSEcCtD
Clonazepam—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.56e-05	0.000346	CcSEcCtD
Clonazepam—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.52e-05	0.000344	CcSEcCtD
Clonazepam—Pruritus—Methotrexate—urinary bladder cancer	4.52e-05	0.000343	CcSEcCtD
Clonazepam—NAT2—Metabolism—GPX1—urinary bladder cancer	4.44e-05	0.000578	CbGpPWpGaD
Clonazepam—Hypersensitivity—Epirubicin—urinary bladder cancer	4.4e-05	0.000335	CcSEcCtD
Clonazepam—Urticaria—Doxorubicin—urinary bladder cancer	4.39e-05	0.000334	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	4.38e-05	0.000569	CbGpPWpGaD
Clonazepam—Abdominal pain—Doxorubicin—urinary bladder cancer	4.37e-05	0.000332	CcSEcCtD
Clonazepam—Body temperature increased—Doxorubicin—urinary bladder cancer	4.37e-05	0.000332	CcSEcCtD
Clonazepam—Diarrhoea—Methotrexate—urinary bladder cancer	4.37e-05	0.000332	CcSEcCtD
Clonazepam—NAT2—Metabolism—ERCC2—urinary bladder cancer	4.36e-05	0.000567	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	4.32e-05	0.000562	CbGpPWpGaD
Clonazepam—Asthenia—Epirubicin—urinary bladder cancer	4.29e-05	0.000326	CcSEcCtD
Clonazepam—Pruritus—Epirubicin—urinary bladder cancer	4.23e-05	0.000321	CcSEcCtD
Clonazepam—Dizziness—Methotrexate—urinary bladder cancer	4.22e-05	0.000321	CcSEcCtD
Clonazepam—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	4.19e-05	0.000545	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—MTHFR—urinary bladder cancer	4.1e-05	0.000533	CbGpPWpGaD
Clonazepam—Diarrhoea—Epirubicin—urinary bladder cancer	4.09e-05	0.000311	CcSEcCtD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.09e-05	0.000531	CbGpPWpGaD
Clonazepam—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.07e-05	0.00031	CcSEcCtD
Clonazepam—Vomiting—Methotrexate—urinary bladder cancer	4.06e-05	0.000309	CcSEcCtD
Clonazepam—ALB—Folate Metabolism—TNF—urinary bladder cancer	4.05e-05	0.000526	CbGpPWpGaD
Clonazepam—Rash—Methotrexate—urinary bladder cancer	4.03e-05	0.000306	CcSEcCtD
Clonazepam—Dermatitis—Methotrexate—urinary bladder cancer	4.02e-05	0.000306	CcSEcCtD
Clonazepam—Headache—Methotrexate—urinary bladder cancer	4e-05	0.000304	CcSEcCtD
Clonazepam—Asthenia—Doxorubicin—urinary bladder cancer	3.97e-05	0.000301	CcSEcCtD
Clonazepam—Dizziness—Epirubicin—urinary bladder cancer	3.95e-05	0.0003	CcSEcCtD
Clonazepam—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.93e-05	0.000511	CbGpPWpGaD
Clonazepam—Pruritus—Doxorubicin—urinary bladder cancer	3.91e-05	0.000297	CcSEcCtD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.9e-05	0.000507	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	3.83e-05	0.000499	CbGpPWpGaD
Clonazepam—Vomiting—Epirubicin—urinary bladder cancer	3.8e-05	0.000289	CcSEcCtD
Clonazepam—Nausea—Methotrexate—urinary bladder cancer	3.79e-05	0.000288	CcSEcCtD
Clonazepam—Diarrhoea—Doxorubicin—urinary bladder cancer	3.78e-05	0.000287	CcSEcCtD
Clonazepam—Rash—Epirubicin—urinary bladder cancer	3.77e-05	0.000286	CcSEcCtD
Clonazepam—Dermatitis—Epirubicin—urinary bladder cancer	3.76e-05	0.000286	CcSEcCtD
Clonazepam—Headache—Epirubicin—urinary bladder cancer	3.74e-05	0.000284	CcSEcCtD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.74e-05	0.000486	CbGpPWpGaD
Clonazepam—Dizziness—Doxorubicin—urinary bladder cancer	3.66e-05	0.000278	CcSEcCtD
Clonazepam—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	3.64e-05	0.000473	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NAT1—urinary bladder cancer	3.64e-05	0.000473	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TP53—urinary bladder cancer	3.57e-05	0.000464	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	3.55e-05	0.000462	CbGpPWpGaD
Clonazepam—Nausea—Epirubicin—urinary bladder cancer	3.55e-05	0.00027	CcSEcCtD
Clonazepam—Vomiting—Doxorubicin—urinary bladder cancer	3.52e-05	0.000267	CcSEcCtD
Clonazepam—Rash—Doxorubicin—urinary bladder cancer	3.49e-05	0.000265	CcSEcCtD
Clonazepam—Dermatitis—Doxorubicin—urinary bladder cancer	3.48e-05	0.000265	CcSEcCtD
Clonazepam—Headache—Doxorubicin—urinary bladder cancer	3.46e-05	0.000263	CcSEcCtD
Clonazepam—NAT2—Metabolism—PPARG—urinary bladder cancer	3.33e-05	0.000432	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	3.32e-05	0.000432	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTZ1—urinary bladder cancer	3.3e-05	0.000429	CbGpPWpGaD
Clonazepam—Nausea—Doxorubicin—urinary bladder cancer	3.28e-05	0.00025	CcSEcCtD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.27e-05	0.000425	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	3.22e-05	0.000418	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CREBBP—urinary bladder cancer	3.19e-05	0.000415	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTO2—urinary bladder cancer	3.12e-05	0.000406	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NAT1—urinary bladder cancer	3.12e-05	0.000406	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.07e-05	0.0004	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.07e-05	0.0004	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	2.99e-05	0.000389	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.93e-05	0.000381	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	2.9e-05	0.000378	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.86e-05	0.000372	CbGpPWpGaD
Clonazepam—ALB—Metabolism—UGT2B7—urinary bladder cancer	2.86e-05	0.000372	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	2.83e-05	0.000368	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.81e-05	0.000365	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	2.75e-05	0.000358	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	2.75e-05	0.000358	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.72e-05	0.000353	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.67e-05	0.000347	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.66e-05	0.000345	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.63e-05	0.000342	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS2—urinary bladder cancer	2.62e-05	0.00034	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.59e-05	0.000337	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP4B1—urinary bladder cancer	2.57e-05	0.000335	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	2.52e-05	0.000328	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.48e-05	0.000323	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.46e-05	0.000319	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IFNA2—urinary bladder cancer	2.45e-05	0.000319	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC19A1—urinary bladder cancer	2.43e-05	0.000316	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PRSS3—urinary bladder cancer	2.37e-05	0.000308	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—HRAS—urinary bladder cancer	2.35e-05	0.000306	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTEN—urinary bladder cancer	2.28e-05	0.000297	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—HRAS—urinary bladder cancer	2.25e-05	0.000292	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TYMP—urinary bladder cancer	2.2e-05	0.000286	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—EP300—urinary bladder cancer	2.18e-05	0.000283	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.17e-05	0.000282	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—HRAS—urinary bladder cancer	2.15e-05	0.00028	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.11e-05	0.000275	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NAT2—urinary bladder cancer	1.99e-05	0.000259	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.9e-05	0.000247	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TYMP—urinary bladder cancer	1.89e-05	0.000246	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—HRAS—urinary bladder cancer	1.88e-05	0.000245	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.84e-05	0.00024	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.82e-05	0.000236	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.78e-05	0.000231	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PLAU—urinary bladder cancer	1.74e-05	0.000226	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—RRM2—urinary bladder cancer	1.72e-05	0.000224	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NAT2—urinary bladder cancer	1.71e-05	0.000223	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.69e-05	0.000219	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.69e-05	0.000219	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ENO2—urinary bladder cancer	1.59e-05	0.000207	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	1.59e-05	0.000207	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	1.54e-05	0.000201	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.54e-05	0.000201	CbGpPWpGaD
Clonazepam—ALB—Metabolism—RRM2—urinary bladder cancer	1.48e-05	0.000192	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.44e-05	0.000187	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IGF1—urinary bladder cancer	1.42e-05	0.000184	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.39e-05	0.000181	CbGpPWpGaD
Clonazepam—ALB—Metabolism—HPGDS—urinary bladder cancer	1.37e-05	0.000178	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ENO2—urinary bladder cancer	1.37e-05	0.000178	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.36e-05	0.000177	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTT1—urinary bladder cancer	1.33e-05	0.000173	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.31e-05	0.000171	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.31e-05	0.00017	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RHOA—urinary bladder cancer	1.3e-05	0.000169	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.28e-05	0.000167	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.28e-05	0.000166	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.24e-05	0.000162	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NQO1—urinary bladder cancer	1.1e-05	0.000143	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IL2—urinary bladder cancer	1.09e-05	0.000142	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.07e-05	0.000139	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.07e-05	0.000139	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.02e-05	0.000133	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TYMS—urinary bladder cancer	9.95e-06	0.000129	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	9.84e-06	0.000128	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	9.84e-06	0.000128	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—EP300—urinary bladder cancer	9.78e-06	0.000127	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SRC—urinary bladder cancer	9.51e-06	0.000124	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GPX1—urinary bladder cancer	9.42e-06	0.000122	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.33e-06	0.000121	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	9.25e-06	0.00012	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NAT2—urinary bladder cancer	9.24e-06	0.00012	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTP1—urinary bladder cancer	9.2e-06	0.00012	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.9e-06	0.000116	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	8.69e-06	0.000113	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TYMS—urinary bladder cancer	8.55e-06	0.000111	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NCOR1—urinary bladder cancer	8.45e-06	0.00011	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTM1—urinary bladder cancer	8.45e-06	0.00011	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GPX1—urinary bladder cancer	8.1e-06	0.000105	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—RRM2—urinary bladder cancer	7.98e-06	0.000104	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ERCC2—urinary bladder cancer	7.95e-06	0.000103	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—KRAS—urinary bladder cancer	7.87e-06	0.000102	CbGpPWpGaD
Clonazepam—ALB—Metabolism—MTHFR—urinary bladder cancer	7.47e-06	9.72e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7.39e-06	9.61e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7.39e-06	9.61e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.17e-06	9.32e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PPARG—urinary bladder cancer	7.05e-06	9.17e-05	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TP53—urinary bladder cancer	7e-06	9.1e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	6.77e-06	8.81e-05	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—HRAS—urinary bladder cancer	6.69e-06	8.7e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PPARG—urinary bladder cancer	6.06e-06	7.88e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NQO1—urinary bladder cancer	5.95e-06	7.74e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CREBBP—urinary bladder cancer	5.82e-06	7.57e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	5.55e-06	7.21e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.97e-06	6.46e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTEN—urinary bladder cancer	4.84e-06	6.29e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS2—urinary bladder cancer	4.77e-06	6.2e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.62e-06	6e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—EP300—urinary bladder cancer	4.61e-06	6e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.56e-06	5.93e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.56e-06	5.93e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.37e-06	5.68e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.29e-06	5.58e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTEN—urinary bladder cancer	4.16e-06	5.4e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.03e-06	5.24e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—EP300—urinary bladder cancer	3.96e-06	5.15e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.27e-06	4.25e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.14e-06	4.09e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.57e-06	3.35e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.24e-06	2.92e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.14e-06	2.78e-05	CbGpPWpGaD
